{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:54:06Z","timestamp":1784026446184,"version":"3.55.0"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Research and Events Support Fund at Hospital de Cl\u00ednicas de Porto Alegre (FIPE-HCPA)"},{"DOI":"10.13039\/501100003810","name":"FIPE-HCPA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Postgraduate Program in Psychiatry and Behavioral Science"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.drugalcdep.2018.08.036","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T13:52:00Z","timestamp":1539352320000},"page":"91-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Brain-derived neurotrophic factor in substance use disorders: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3881-4283","authenticated-orcid":false,"given":"Felipe","family":"Ornell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Barreto","family":"Schuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8693-2452","authenticated-orcid":false,"given":"Fernando","family":"Pezzini Rebelatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Laura","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Nichterwitz","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei Garziera","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Pechansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix Henrique","family":"Paim Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisia","family":"von Diemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1176\/appi.neuropsych.12030060","article-title":"Aggression, impulsivity, and psychopathic traits in combined antisocial personality disorder and substance use disorder","volume":"25","author":"Alcorn","year":"2013","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-6147(99)01309-7","article-title":"Neurotrophins and depression","volume":"20","author":"Altar","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association (APA)","year":"2013"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1369-1600.2010.00221.x","article-title":"Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms","volume":"15","author":"Angelucci","year":"2010","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/156720510790274473","article-title":"Alzheimer\u2019s Disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels","volume":"7","author":"Angelucci","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jneuroim.2005.07.001","article-title":"Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate","volume":"167","author":"Azoulay","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2014.10.058","article-title":"Brain-derived neurotrophic factor and addiction: pathological versus therapeutic effects on drug seeking","volume":"1628","author":"Barker","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0045","series-title":"Pesquisa nacional sobre o uso de crack: Quem s\u00e3o os usu\u00e1rios de crack e\/ou similares do Brasil? Quantos s\u00e3o nas capitais brasileiras? Editora Fiocruz, Rio de Janeiro","first-page":"224","author":"Bastos","year":"2014"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0050","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/humrep\/del479","article-title":"Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor","volume":"22","author":"Begliuomini","year":"2007","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1073858407305850","article-title":"BDNF and memory formation and storage","volume":"14","author":"Bekinschtein","year":"2008","journal-title":"Neuroscientist"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0060","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08977190410001723308","article-title":"Brain-derived neurotrophic factor","volume":"22","author":"Binder","year":"2004","journal-title":"Growth Factors"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0070","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3109\/15622971003611319","article-title":"Serum and plasma BDNF levels in major depression: a replication study and meta-analyses","volume":"11","author":"Bocchio-Chiavetto","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1385\/NMM:5:1:069","article-title":"Neurotrophic mechanisms in drug addiction","volume":"5","author":"Bola\u00f1os","year":"2004","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0080","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.psyneuen.2010.07.013","article-title":"Determinants of serum brain-derived neurotrophic factor","volume":"36","author":"Bus","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0085","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2990.2010.01131.x","article-title":"Review: the neuropathology of drug abuse","volume":"37","author":"B\u00fcttner","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1385\/MN:29:3:289","article-title":"Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection","volume":"29","author":"Castr\u00e9n","year":"2004","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0095","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/978-3-642-45106-5_17","article-title":"Neurotrophins and psychiatric disorders","volume":"220","author":"Castr\u00e9n","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0100","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5455\/bcp.20120731055756","article-title":"Alterations in serum BDNF levels in early alcohol withdrawal and comparison with healthy controls","volume":"22","author":"Cavus","year":"2012","journal-title":"Bull. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0105","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ajmg.b.30501","article-title":"Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington\u2019s disease patients","volume":"144B","author":"Ciammola","year":"2007","journal-title":"Am. J. Med. Genet. B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tics.2010.06.007","article-title":"Cognitive theory and therapy of anxiety and depression: convergence with neurobiological findings","volume":"14","author":"Clark","year":"2010","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0115","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1176\/appi.ajp.162.8.1494","article-title":"Developments in the epidemiology of drug use and drug use disorders","volume":"162","author":"Compton","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0120","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jat\/19.6.459","article-title":"Pharmacokinetics and pharmacodynamics of cocaine","volume":"19","author":"Cone","year":"1995","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0169-328X(97)00125-3","article-title":"Brain-derived neurotrophic factor is reduced in Alzheimer\u2019s disease","volume":"49","author":"Connor","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0130","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.euroneuro.2012.08.016","article-title":"Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence","volume":"23","author":"Corominas-Roso","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.psychres.2014.12.019","article-title":"Changes in brain-derived neurotrophic factor (BDNF) during abstinence could be associated with relapse in cocaine-dependent patients","volume":"225","author":"Corominas-Roso","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0140","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/j.1530-0277.2011.01548.x","article-title":"Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal","volume":"35","author":"Costa","year":"2011","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0145","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.biopsych.2011.05.013","article-title":"Increased serum brain-derived neurotrophic factor is predictive of cocaine relapse outcomes: a prospective study","volume":"70","author":"D\u2019Sa","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.alcohol.2011.12.001","article-title":"Serum and plasma brain-derived neurotrophic factor (BDNF) in abstinent alcoholics and social drinkers","volume":"46","author":"D\u2019Sa","year":"2012","journal-title":"Alcohol"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0155","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00213-008-1333-2","article-title":"Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans","volume":"202","author":"D\u2019Souza","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0160","first-page":"309","article-title":"Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury","volume":"147","author":"Donovan","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0165","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0170","first-page":"89","article-title":"A nonparametric \u201ctrim and fill\u201d method of accounting for publication bias in meta-analysis","volume":"95","author":"Duval","year":"2000","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0175","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0180","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1523\/JNEUROSCI.6251-09.2010","article-title":"Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume","volume":"30","author":"Erickson","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0185","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1073\/pnas.1015950108","article-title":"Exercise training increases size of hippocampus and improves memory","volume":"108","author":"Erickson","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.nmd.0000131913.94916.d5","article-title":"The prevalence of psychiatric disorder among a community sample of crack cocaine users: an exploratory study with practical implications","volume":"192","author":"Falck","year":"2004","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0195","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jpsychires.2011.03.002","article-title":"Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis","volume":"45","author":"Fernandes","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0200","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/mp.2013.172","article-title":"Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis","volume":"19","author":"Fernandes","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12916-015-0529-7","article-title":"Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies","volume":"13","author":"Fernandes","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0210","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/mp.2014.117","article-title":"Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications","volume":"20","author":"Fernandes","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0215","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1055\/s-0037-1613072","article-title":"Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation","volume":"87","author":"Fujimura","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.rbp.2012.09.001","article-title":"Staging and neuroprogression in bipolar disorder: a systematic review of the literature","volume":"35","author":"Gama","year":"2013","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0225","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.psychres.2016.04.007","article-title":"Serum levels of brain-derived neurotrophic factor in alcohol-dependent patients receiving high-dose baclofen","volume":"240","author":"Geisel","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0230","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/bs.vh.2016.10.009","article-title":"BDNF during withdrawal","volume":"104","author":"Geoffroy","year":"2017","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0235","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neubiorev.2010.05.002","article-title":"Individual differences in prefrontal cortex function and the transition from drug use to drug dependence","volume":"35","author":"George","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0240","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.physbeh.2011.11.004","article-title":"Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems","volume":"106","author":"George","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0245","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1176\/appi.ajp.159.10.1642","article-title":"Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex","volume":"159","author":"Goldstein","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0250","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nn1929","article-title":"Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse","volume":"10","author":"Graham","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.physbeh.2011.10.029","article-title":"Mediators of allostasis and systemic toxicity in bipolar disorder","volume":"106","author":"Grande","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0260","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1523\/JNEUROSCI.23-03-00742.2003","article-title":"Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving","volume":"23","author":"Grimm","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0265","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.pnpbp.2006.06.018","article-title":"Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism","volume":"30","author":"Hashimoto","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0270","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00213-010-1781-3","article-title":"BDNF plasma levels decrease during benzodiazepine withdrawal in patients suffering from comorbidity of depressive disorder and benzodiazepine dependence","volume":"209","author":"Heberlein","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0275","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","year":"2011"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0280","first-page":"357","article-title":"Is serum brain-derived neurotrophic factor related to craving for or use of alcohol, cocaine, or methamphetamine?","volume":"7","author":"Hilburn","year":"2011","journal-title":"Neuropsychiatr. J. Sleep Disord. Treat. Care"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0285","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.alcohol.2014.08.007","article-title":"Genetic and behavioral determinants of hippocampal volume recovery during abstinence from alcohol","volume":"48","author":"Hoefer","year":"2014","journal-title":"Alcohol"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0290","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: roles in neuronal development and function","volume":"24","author":"Huang","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0295","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1530-0277.2010.01329.x","article-title":"Differential patterns of serum brain-derived neurotrophic factor levels in alcoholic patients with and without delirium tremens during acute withdrawal","volume":"35","author":"Huang","year":"2011","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0300","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1046\/j.1471-4159.2003.02216.x","article-title":"Diazepam-induced adaptive plasticity revealed by alpha1 GABAA receptor-specific expression profiling","volume":"88","author":"Huopaniemi","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0305","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/ntr\/ntu151","article-title":"Association between smoking, nicotine dependence, and BDNF Val66Met polymorphism with BDNF concentrations in serum","volume":"17","author":"Jamal","year":"2015","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0310","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neubiorev.2007.10.005","article-title":"Allostatic load in bipolar disorder: implications for pathophysiology and treatment","volume":"32","author":"Kapczinski","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0315","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/acps.12305","article-title":"Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force report","volume":"130","author":"Kapczinski","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0320","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0304-3940(02)00529-3","article-title":"Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets","volume":"328","author":"Karege","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0325","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drugalcdep.2014.06.043","article-title":"Serum brain-derived neurotrophic factor and nerve growth factor decreased in chronic ketamine abusers","volume":"142","author":"Ke","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0330","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1084\/jem.189.5.865","article-title":"Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?","volume":"189","author":"Kerschensteiner","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0335","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0340","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fpsyt.2017.00308","article-title":"Brain-derived neurotrophic factor and major depressive disorder: evidence from meta-analyses","volume":"8","author":"Kishi","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0345","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00001756-200104170-00040","article-title":"Analysis of effects and pharmacokinetics of subcutaneously administered BDNF","volume":"12","author":"Kishino","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0350","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","article-title":"Drugs of abuse: anatomy, pharmacology and function of reward pathways","volume":"13","author":"Koob","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0355","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1749-6632.2000.tb06682.x","article-title":"Neurobiology of addiction. Toward the development of new therapies","volume":"909","author":"Koob","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0360","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neubiorev.2003.11.007","article-title":"Neurobiological mechanisms in the transition from drug use to drug dependence","volume":"27","author":"Koob","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0365","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00125-006-0537-4","article-title":"Brain-derived neurotrophic factor (BDNF) and type 2 diabetes","volume":"50","author":"Krabbe","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0370","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4306\/pi.2009.6.4.299","article-title":"Decreased serum brain-derived neurotrophic factor levels in elderly Korean with dementia","volume":"6","author":"Lee","year":"2009","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0375","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1126\/science.278.5335.45","article-title":"Addiction is a brain disease, and it matters","volume":"278","author":"Leshner","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0380","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.psc.2006.04.013","article-title":"Treating incarcerated women: gender matters","volume":"29","author":"Lewis","year":"2006","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0385","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbr.2014.11.018","article-title":"Multiple faces of BDNF in cocaine addiction","volume":"279","author":"Li","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0390","doi-asserted-by":"crossref","first-page":"e84806","DOI":"10.1371\/journal.pone.0084806","article-title":"Alterations in brain-derived neurotrophic factor in the mouse hippocampus following acute but not repeated benzodiazepine treatment","volume":"8","author":"Licata","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0395","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brainres.2015.03.025","article-title":"Corticostriatal BDNF and alcohol addiction","volume":"1628","author":"Logrip","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0400","doi-asserted-by":"crossref","first-page":"e724","DOI":"10.1161\/CIRCULATIONAHA.105.594135","article-title":"Letter regarding article by Ejiri et al., \"possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease\"","volume":"113","author":"Lommatzsch","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0405","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1164\/rccm.200406-758OC","article-title":"Brain-derived neurotrophic factor in platelets and airflow limitation in asthma","volume":"171","author":"Lommatzsch","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0410","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2004.03.002","article-title":"The impact of age, weight and gender on BDNF levels in human platelets and plasma","volume":"26","author":"Lommatzsch","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0415","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM199801153380307","article-title":"Protective and damaging effects of stress mediators","volume":"338","author":"McEwen","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0420","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.1998.tb09546.x","article-title":"Stress, adaptation, and disease. Allostasis and allostatic load","volume":"840","author":"McEwen","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0425","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0893-133X(99)00129-3","article-title":"Allostasis and allostatic load: implications for neuropsychopharmacology","volume":"22","author":"McEwen","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0430","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0197-4580(02)00027-1","article-title":"Sex, stress and the hippocampus: allostasis, allostatic load and the aging process","volume":"23","author":"McEwen","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0435","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0006-3223(03)00177-X","article-title":"Mood disorders and allostatic load","volume":"54","author":"McEwen","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0440","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0018-506X(02)00024-7","article-title":"The concept of allostasis in biology and biomedicine","volume":"43","author":"McEwen","year":"2003","journal-title":"Horm. Behav."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0445","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/157015911795017128","article-title":"Developing biomarkers for methamphetamine addiction","volume":"9","author":"Mendelson","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0450","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/1874473710902010076","article-title":"The role of glial cells in drug abuse","volume":"2","author":"Miguel-Hidalgo","year":"2009","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0455","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0460","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/mp.2015.54","article-title":"Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis","volume":"21","author":"Munkholm","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0465","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0301-0082(00)00014-9","article-title":"Brain-derived neurotrophic factor in the control human brain, and in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"63","author":"Murer","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0470","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrd3366","article-title":"Potential therapeutic uses of BDNF in neurological and psychiatric disorders","volume":"10","author":"Nagahara","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0475","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-5793(00)01302-8","article-title":"Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor","volume":"470","author":"Nakahashi","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0480","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.comppsych.2014.04.021","article-title":"Psychiatric and substance-use comorbidities associated with lifetime crack cocaine use in young adults in the general population","volume":"55","author":"Narvaez","year":"2014","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0485","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-8993(97)01525-4","article-title":"Permeability of the blood-brain barrier to neurotrophins","volume":"788","author":"Pan","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0490","first-page":"477","article-title":"Substance use and related problems: a study on the abuse of recreational and not recreational drugs in Northern Italy","volume":"42","author":"Pavarin","year":"2006","journal-title":"Ann. Ist. Super Sanita"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0495","doi-asserted-by":"crossref","first-page":"e0118610","DOI":"10.1371\/journal.pone.0118610","article-title":"Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidity","volume":"10","author":"Pedraz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0500","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jad.2007.05.005","article-title":"Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments","volume":"105","author":"Piccinni","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0505","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0169-328X(95)00250-V","article-title":"Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF","volume":"36","author":"Poduslo","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0510","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","article-title":"BDNF as a biomarker for successful treatment of mood disorders: a systematic and quantitative meta-analysis","volume":"174","author":"Polyakova","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0515","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/mp.2016.62","article-title":"Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer\u2019s disease: a meta-analysis study (N\u2009=\u20097277)","volume":"22","author":"Qin","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0520","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1113\/expphysiol.2009.048512","article-title":"Evidence for a release of brain-derived neurotrophic factor from the brain during exercise","volume":"94","author":"Rasmussen","year":"2009","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0525","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jad.2017.06.017","article-title":"Brain-derived neurotrophic factor levels and depression during methamphetamine withdrawal","volume":"221","author":"Ren","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0530","doi-asserted-by":"crossref","first-page":"109","DOI":"10.9758\/cpn.2016.14.1.109","article-title":"Cocaine-induced psychosis and brain-derived neurothrophic factor in patients with cocaine dependence: report of two cases","volume":"14","author":"Roncero","year":"2016","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2018.08.036_bib0535","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuropharm.2008.06.059","article-title":"Neurotrophic factors and structural plasticity in addiction","volume":"56","author":"Russo","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0540","doi-asserted-by":"crossref","first-page":"e00706","DOI":"10.1002\/brb3.706","article-title":"Decrease in brain-derived neurotrophic factor at plasma level but not in serum concentrations in suicide behavior: a systematic review and meta-analysis","volume":"7","author":"Salas-Maga\u00f1a","year":"2017","journal-title":"Brain Behav."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0545","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.addbeh.2013.10.021","article-title":"Rate of progression from first use to dependence on cocaine or opioids: a cross-substance examination of associated demographic, psychiatric, and childhood risk factors","volume":"39","author":"Sartor","year":"2014","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0550","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.drugalcdep.2015.07.535","article-title":"Higher levels of BDNF are associated with inpatient treatment adherence of crack-cocaine users","volume":"156","author":"Scherer","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0555","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1038\/npp.2010.114","article-title":"Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models","volume":"35","author":"Schmidt","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0560","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/15563650.2010.516263","article-title":"Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation","volume":"48","author":"Seger","year":"2010","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0565","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5498\/wjp.v6.i1.84","article-title":"Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?","volume":"6","author":"Serra-Mill\u00e0s","year":"2016","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0570","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3934\/Neuroscience.2016.4.398","article-title":"Risk and resilience: the role of brain-derived neurotrophic factor in alcohol use disorder","volume":"3","author":"Sharma","year":"2016","journal-title":"AIMS Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0575","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pbb.2016.12.002","article-title":"Stress-induced change in serum BDNF is related to quantitative family history of alcohol use disorder and age at first alcohol use","volume":"153","author":"Sharma","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0580","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-3223(03)00181-1","article-title":"Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants","volume":"54","author":"Shimizu","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0585","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11920-011-0224-0","article-title":"New findings on biological factors predicting addiction relapse vulnerability","volume":"13","author":"Sinha","year":"2011","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0590","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.yfrne.2006.09.003","article-title":"Estrogen-BDNF interactions: implications for neurodegenerative diseases","volume":"27","author":"Sohrabji","year":"2006","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0595","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1007\/s00213-014-3542-1","article-title":"Oxidative stress and BDNF as possible markers for the severity of crack cocaine use in early withdrawal","volume":"231","author":"Sordi","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0600","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fpsyt.2013.00068","article-title":"The role of the glucocorticoids in developing resilience to stress and addiction","volume":"4","author":"Srinivasan","year":"2013","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0605","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00127-015-1104-4","article-title":"Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study","volume":"51","author":"Toftdahl","year":"2015","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0610","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainresbull.2007.03.009","article-title":"Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data","volume":"73","author":"Trajkovska","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0615","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hup.1035","article-title":"Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence","volume":"24","author":"Umene-Nakano","year":"2009","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0620","doi-asserted-by":"crossref","first-page":"901082","DOI":"10.1155\/2013\/901082","article-title":"Serum brain-derived neurotrophic factor levels in different neurological diseases","volume":"2013","author":"Ventriglia","year":"2013","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0625","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1503\/jpn.130027","article-title":"Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress","volume":"39","author":"Viola","year":"2014","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0630","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.neuroimage.2009.10.088","article-title":"Cognitive control of drug craving inhibits brain reward regions in cocaine abusers","volume":"49","author":"Volkow","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0635","doi-asserted-by":"crossref","first-page":"15037","DOI":"10.1073\/pnas.1010654108","article-title":"Addiction: beyond dopamine reward circuitry","volume":"108","author":"Volkow","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0640","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1021\/acschemneuro.5b00067","article-title":"Biomarkers in substance use disorders","volume":"6","author":"Volkow","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0645","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S146114571300103X","article-title":"Increase in brain-derived neurotrophic factor expression in early crack cocaine withdrawal","volume":"17","author":"von Diemen","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0650","series-title":"The Newcastle\u2013Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis","author":"Wells","year":"2014"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0655","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/archpsyc.1973.01750350005001","article-title":"Dynamics of drug dependence. Implications of a conditioning theory for research and treatment","volume":"28","author":"Wikler","year":"1973","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0660","series-title":"World Health Organization (WHO). International Classification of Diseases (ICD-10)","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0665","doi-asserted-by":"crossref","first-page":"9051","DOI":"10.1038\/srep09051","article-title":"Coffee consumption and bladder cancer: a meta-analysis of observational studies","volume":"5","author":"Wu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0670","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1523\/JNEUROSCI.10-11-03469.1990","article-title":"Human platelets contain brain-derived neurotrophic factor","volume":"10","author":"Yamamoto","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0675","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00406-006-0652-8","article-title":"Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer\u2019s disease and vascular dementia","volume":"256","author":"Yasutake","year":"2006","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0680","first-page":"1529","article-title":"Alterations of brain-derived neurotrophic factor serum levels in patients with alcohol dependence","volume":"35","author":"Zanardini","year":"2011","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0685","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neulet.2014.04.048","article-title":"Increased serum brain-derived neurotrophic factor levels during opiate withdrawal","volume":"571","author":"Zhang","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0690","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.drugalcdep.2018.08.036_bib0695","doi-asserted-by":"crossref","first-page":"e22966","DOI":"10.1371\/journal.pone.0022966","article-title":"Brain-derived neurotrophic factor in patients with Huntington\u2019s disease","volume":"6","author":"Zuccato","year":"2011","journal-title":"PLoS One"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618307257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618307257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:55:45Z","timestamp":1759827345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618307257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":139,"alternative-id":["S0376871618307257"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.08.036","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain-derived neurotrophic factor in substance use disorders: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.08.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}